Literature DB >> 3517092

Reproductive performance of dairy cows with cystic ovaries following administration of Procystin.

R L Ax, M E Bellin, D K Schneider, J A Haase-Hardie, S E Mares.   

Abstract

Eighty-five postpartum Holstein cows were randomly assigned to receive 0, 50, 100, or 250 micrograms of the gonadotropin-releasing hormone product, Procystin when follicular cysts were diagnosed by palpation per rectum. Accurate reproductive records were maintained, and milk samples were collected at the time of diagnoses for assay for progesterone. An additional 101 cows were injected with only the 100 micrograms dose of Procystin when cysts were identified. Data showed that days from treatment to first observed estrus decreased with increasing doses of Procystin with no advantage of 250 micrograms over 100 micrograms. Days open and conception rates were similar among the treatment groups. Cows with less than 1 ng/ml progesterone in their milk at the time of treatment returned to estrus sooner than cows with progesterone concentrations greater than 1 ng/ml. In addition, gonadotropin-releasing hormone administered to those cows with low progesterone at the time of treatment led to significantly increased progesterone concentrations by 7 and 14 d posttreatment. We conclude that although Procystin administration hastened estrus of cows with ovarian cysts, breeding practices on the farms did not lead to an improvement in reproductive efficiency of the cows that possessed cysts.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3517092     DOI: 10.3168/jds.S0022-0302(86)80435-0

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  2 in total

1.  Recovery rate and recovery time in cows with luteal and follicular ovarian cysts after treatment with buserelin.

Authors:  M C Veronesi; M Battocchio; F Cairoli; A Comin; M Isola
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

2.  Bovine uterine, cervical and ovarian cytosol estrogen and progesterone receptor concentrations in cystic ovarian disease.

Authors:  M Vesanen
Journal:  Acta Vet Scand       Date:  1993       Impact factor: 1.695

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.